燃焼後の死亡率と臨床結果に対するBMIの影響
Julia Kleinhapl1,2, Rudy Ji3, Lucineia Gainski Danielski1
1Department of Surgery, Division of Surgical Sciences, University of Texas Medical Branch, Galveston, TX 77555, USA.
European burn journal
|February 20, 2026
まとめ
低体重の灼熱患者は,より高い死亡率と合併症に直面します. 対照的に,肥満や肥満の個人は,より高い生存率を示し,生存率を支えています.
科学分野:
- バーン・リサーチ
- クリニカルアウトカム
- 患者様を分層化しています.
背景:
- 極端な体重は患者の罹患率に影響しますが,燃焼の結果に対する影響は十分に研究されていません.
- 以前の研究では,燃焼ケアにおける"肥満パラドックス"が示唆されており,肥満患者にとってより良い結果を示している.
研究 の 目的:
- ボディ・マス・インデックス (BMI) と,成人灼熱患者における臨床結果との関連を調査する.
- BMIのカテゴリーに基づいて,異なるリスクサブグループを特定します.
主な方法:
- 大人の火傷患者のためのTrinetXの現実世界データベースを利用しました.
- 雇用者 1: 1 の傾向スコアは,人口統計,火傷の重症度,および煙の吸入に匹敵します.
- 死亡率,セプシス,肺炎,AKI,心血管疾患,心理的障害を含む6ヶ月の臨床結果を分析した.
主要な成果:
- 体重不足の患者は,より高い死亡率とセプシス,肺炎,心血管疾患,心理的障害のリスクの増加を示した.
- 体重過多および肥満の患者は,より高い生存率とよりよい全体的な臨床結果と関連していました.
- 体重不足対正常,体重過剰対正常,肥満対正常,体重不足対肥満の比較で,有意なサンプルサイズが達成されました.
結論:
- 研究結果は,火傷ケアにおける"肥満パラドックス"と一致しています.
- 低体重の灼熱患者は,特別な注意を必要とする高リスクサブグループを表しています.
- BMIは,火傷患者の結果に影響を与える重要な要因です.
関連する概念動画
Burn Injuries
4.8K
Burn injuries occur when the skin and underlying tissues are damaged due to exposure to heat, electricity, chemicals, radiation, or friction. They can vary in severity, from minor superficial burns to severe deep burns that can be life-threatening.
The damage results in the death of skin cells, which can lead to a massive loss of fluid. Dehydration, electrolyte imbalance, and renal and circulatory failure follow, which can be fatal. Burn patients are treated with intravenous fluids to offset...
The damage results in the death of skin cells, which can lead to a massive loss of fluid. Dehydration, electrolyte imbalance, and renal and circulatory failure follow, which can be fatal. Burn patients are treated with intravenous fluids to offset...
4.8K
Obesity
1.4K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.4K
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
312
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
312
Drug Dosing: Obese Patients
301
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
301
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
491
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
491


